Daniel Bach
speaker
1,877 appearances
52 recordings
2 series
first heard Aug 2025
last heard yesterday
Daniel Bach’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 50 in all, peaking in Feb 2026 with 15.
Appearances
WSJ Minute Briefing · Trump Plans to Gut Legal Basis for Greenhouse Gas Regulation · 10 Feb 2026
podcast
with, quote, the respect that we deserve.
Trump pledged support for the bridge back in 2017, with Canada agreeing to collect tolls that would pay a private sector builder.
And Gucci parent Kering reported better sales trends for the fourth quarter and said it aims to return to growth in 2026 after years of decline.
The Paris-based luxury giant has been trying to draw customers back with a revamp to the core Gucci brand, while contending with a downturn in spending like many of its rivals.
Kering's results come after industry bellwether LVMH recorded sluggish sales growth for last year's final quarter, which has sparked more investor caution about the sector.
Asian stocks ended the day mostly higher.
European stocks are also mostly higher in midday trading.
And U.S.
stock futures are flat ahead of earnings from Coca-Cola and Ford.
And we've got a lot more coverage of the day's news on the WSJ's What's News podcast.
You can add it to your playlist on your smart speaker or listen and subscribe wherever you get your podcasts.
Here's your morning brief for Monday, February 9th.
I'm Daniel Bach for The Wall Street Journal.
Japan's benchmark Nikkei Stock Index surged to a record high today after Prime Minister Sanae Takeuchi won a powerful mandate to deepen ties with the U.S.
and rev up Japan's economy.
The landslide victory in yesterday's elections gives Takeuchi's government a more than two-thirds majority in Japan's lower house, and the ability to overrule the smaller upper house to push through its agenda.
That helped push Asian stocks to end the day higher, with European shares also gaining in midday trading.
The move came after the Food and Drug Administration threatened to restrict access to the ingredients needed for compounding pharmacies to copy popular GLP-1 medicines.
Shares of HIMS and HERS are down more than 15 percent in off-hours trading since Friday's U.S.
close.
Showing 1621–1640 of 1,877 · page 82 of 94
← Previous
Next →